MET and non-small cell lung carcinoma: In addition, MET alterations are suggested to be one of the major uncommon oncogenic alterations in NSCLC [5], and the latest research identified the important role of MET amplification in accelerating the growth of tumors and predicting the poor prognosis of patients with malignancies [6, 7].